Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 292

1.

The "ultimate" haploidentical transplantation for the elderly with high-risk acute myeloid leukemia.

Pierini A, Ruggeri L, Carotti A, Falzetti F, Piccinelli S, Saldi S, Lancellotta V, Aristei C, Velardi A, Martelli MF.

Bone Marrow Transplant. 2019 Aug;54(Suppl 2):803-805. doi: 10.1038/s41409-019-0618-x. Review. No abstract available.

PMID:
31431718
2.

T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease.

Pierini A, Ruggeri L, Mancusi A, Carotti A, Falzetti F, Terenzi A, Martelli MF, Velardi A.

Bone Marrow Transplant. 2019 Aug;54(Suppl 2):775-779. doi: 10.1038/s41409-019-0597-y. Review.

PMID:
31431701
3.

Immune tolerance induction by nonmyeloablative haploidentical HSCT combining T-cell depletion and posttransplant cyclophosphamide.

Aversa F, Bachar-Lustig E, Or-Geva N, Prezioso L, Bonomini S, Manfra I, Monti A, Schifano C, Zlotnikov-Klionsky Y, Martelli MF, Sammarelli G, Sassi M, Soli M, Giuliodori S, Benecchi M, Giuliani N, Lohr F, Pratissoli S, Reisner Y.

Blood Adv. 2017 Oct 30;1(24):2166-2175. doi: 10.1182/bloodadvances.2017009423. eCollection 2017 Nov 14.

4.

Clinical-Grade-Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell-Dependent Graft-versus-Leukemia Effect in Murine Models.

Del Papa B, Ruggeri L, Urbani E, Baldoni S, Cecchini D, Zei T, Iacucci Ostini R, Crescenzi B, Carotti A, Pierini A, Sportoletti P, Di Bartolomeo P, Falzetti F, Mecucci C, Velardi A, Martelli MF, Di Ianni M.

Biol Blood Marrow Transplant. 2017 Nov;23(11):1847-1851. doi: 10.1016/j.bbmt.2017.07.009. Epub 2017 Jul 17.

5.

Haploidentical transplants using ex vivo T-cell depletion.

Martelli MF, Aversa F.

Semin Hematol. 2016 Oct;53(4):252-256. doi: 10.1053/j.seminhematol.2016.07.001. Epub 2016 Jul 25. Review.

PMID:
27788763
6.

The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell-Depleted Hematopoietic Stem Cell Transplantation.

Aristei C, Carotti A, Palazzari E, Amico L, Ruggeri L, Perrucci E, Falcinelli L, Lancellotta V, Palumbo I, Falzetti F, Aversa F, Merluzzi M, Velardi A, Martelli MF.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):832-839. doi: 10.1016/j.ijrobp.2016.07.025. Epub 2016 Jul 27.

PMID:
27623308
7.

The NOTCH1/CD39 axis: a Treg trip-switch for GvHD.

Del Papa B, Pierini A, Sportoletti P, Baldoni S, Cecchini D, Rosati E, Dorillo E, Aureli P, Zei T, Iacucci Ostini R, Ruggeri L, Carotti A, Velardi A, Negrin R, Martelli MF, Falzetti F, Di Ianni M.

Leukemia. 2016 Sep;30(9):1931-4. doi: 10.1038/leu.2016.87. Epub 2016 Apr 29. No abstract available.

PMID:
27125307
8.

Next generation HLA-haploidentical HSCT.

Martelli MF, Ianni MD, Ruggeri L, Falzetti F, Carotti A, Reisner Y, Velardi A.

Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S63-6. doi: 10.1038/bmt.2015.98.

PMID:
26039211
9.

Haploidentical hematopoietic stem cell transplantation: state of art.

Reisner Y, Aversa F, Martelli MF.

Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S1-5. doi: 10.1038/bmt.2015.86. Review.

PMID:
26039199
10.

Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality.

Mancusi A, Ruggeri L, Urbani E, Pierini A, Massei MS, Carotti A, Terenzi A, Falzetti F, Tosti A, Topini F, Bozza S, Romani L, Tognellini R, Stern M, Aversa F, Martelli MF, Velardi A.

Blood. 2015 May 14;125(20):3173-82. doi: 10.1182/blood-2014-09-599993. Epub 2015 Mar 13.

11.

Differences in Aspergillus-specific immune recovery between T-cell-replete and T-cell-depleted hematopoietic transplants.

Perruccio K, Topini F, Tosti A, Gazzola MV, Messina C, Martelli MF, Caniglia M, Velardi A, Cesaro S.

Eur J Haematol. 2015 Dec;95(6):551-7. doi: 10.1111/ejh.12531. Epub 2015 Mar 16.

PMID:
25688598
12.

Doing the opposite to what another person is doing.

Bianchi I, Savardi U, Burro R, Martelli MF.

Acta Psychol (Amst). 2014 Sep;151:117-33. doi: 10.1016/j.actpsy.2014.06.003. Epub 2014 Jun 26.

PMID:
24973827
13.

HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse.

Martelli MF, Di Ianni M, Ruggeri L, Falzetti F, Carotti A, Terenzi A, Pierini A, Massei MS, Amico L, Urbani E, Del Papa B, Zei T, Iacucci Ostini R, Cecchini D, Tognellini R, Reisner Y, Aversa F, Falini B, Velardi A.

Blood. 2014 Jul 24;124(4):638-44. doi: 10.1182/blood-2014-03-564401. Epub 2014 Jun 12.

14.

Experts' considerations on HLA-haploidentical stem cell transplantation.

Patriarca F, Luznik L, Medeot M, Zecca M, Bacigalupo A, Di Bartolomeo P, Arcese W, Corradini P, Ciceri F, Vago L, Kanakry CG, Fleischhauer K, Martelli MF, Bosi A, Rambaldi A, Cesaro S, Russo D, Fanin R.

Eur J Haematol. 2014 Sep;93(3):187-97. doi: 10.1111/ejh.12322. Epub 2014 Apr 26.

PMID:
24660868
15.

"Designed" grafts for HLA-haploidentical stem cell transplantation.

Martelli MF, Di Ianni M, Ruggeri L, Pierini A, Falzetti F, Carotti A, Terenzi A, Reisner Y, Aversa F, Falini B, Velardi A.

Blood. 2014 Feb 13;123(7):967-73. doi: 10.1182/blood-2013-10-531764. Epub 2013 Dec 20.

16.

The human NPM1 mutation A perturbs megakaryopoiesis in a conditional mouse model.

Sportoletti P, Varasano E, Rossi R, Bereshchenko O, Cecchini D, Gionfriddo I, Bolli N, Tiacci E, Intermesoli T, Zanghì P, Masciulli A, Martelli MP, Falzetti F, Martelli MF, Falini B.

Blood. 2013 Apr 25;121(17):3447-58. doi: 10.1182/blood-2012-08-449553. Epub 2013 Feb 22.

17.

Neurobehavioral disorders.

Zasler ND, Martelli MF, Jacobs HE.

Handb Clin Neurol. 2013;110:377-88. doi: 10.1016/B978-0-444-52901-5.00032-0. Review.

PMID:
23312657
18.

Mutational landscape of AML with normal cytogenetics: biological and clinical implications.

Martelli MP, Sportoletti P, Tiacci E, Martelli MF, Falini B.

Blood Rev. 2013 Jan;27(1):13-22. doi: 10.1016/j.blre.2012.11.001. Epub 2012 Dec 20. Review.

PMID:
23261068
19.

Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: harnessing natural and adaptive immunity.

Aversa F, Martelli MF, Velardi A.

Semin Oncol. 2012 Dec;39(6):643-52. doi: 10.1053/j.seminoncol.2012.09.002. Review.

PMID:
23206841
20.

Notch1 modulates mesenchymal stem cells mediated regulatory T-cell induction.

Del Papa B, Sportoletti P, Cecchini D, Rosati E, Balucani C, Baldoni S, Fettucciari K, Marconi P, Martelli MF, Falzetti F, Di Ianni M.

Eur J Immunol. 2013 Jan;43(1):182-7. doi: 10.1002/eji.201242643. Epub 2012 Dec 5.

21.

T regulatory cell separation for clinical application.

Di Ianni M, Del Papa B, Zei T, Iacucci Ostini R, Cecchini D, Cantelmi MG, Baldoni S, Sportoletti P, Cavalli L, Carotti A, Pierini A, Falini B, Martelli MF, Falzetti F.

Transfus Apher Sci. 2012 Oct;47(2):213-6. doi: 10.1016/j.transci.2012.06.007. Epub 2012 Jul 12. Review.

PMID:
22795999
22.

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk Hodgkin's lymphoma.

Di Ianni M, Ballanti S, Iodice G, Reale A, Falzetti F, Minelli O, Serio G, Martelli MF, Dammacco F, Vacca A, Ria R.

Hematology. 2012 Jan;17(1):23-7. doi: 10.1179/102453312X13221316477534.

PMID:
22549444
23.

Community based rehabilitation: special issues.

Martelli MF, Zasler ND, Tiernan P.

NeuroRehabilitation. 2012;31(1):3-18. doi: 10.3233/NRE-2012-0770.

PMID:
22523014
24.

Allogeneic hematopoietic stem cell transplantation in patients with diffuse large B cell lymphoma relapsed after autologous stem cell transplantation: a GITMO study.

Rigacci L, Puccini B, Dodero A, Iacopino P, Castagna L, Bramanti S, Ciceri F, Fanin R, Rambaldi A, Falda M, Milone G, Guidi S, Martelli MF, Mazza P, Oneto R, Bosi A; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Ann Hematol. 2012 Jun;91(6):931-9. doi: 10.1007/s00277-011-1395-9. Epub 2012 Jan 14.

PMID:
22245922
25.

Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT.

Perruccio K, Topini F, Tosti A, Carotti A, Burchielli E, Ruggeri L, Mancusi A, Urbani E, Aversa F, Martelli MF, Velardi A.

Bone Marrow Transplant. 2012 Sep;47(9):1196-200. doi: 10.1038/bmt.2011.237. Epub 2011 Dec 5.

PMID:
22139067
26.

High-dose thiotepa, etoposide and carboplatin as conditioning regimen for autologous stem cell transplantation in patients with high-risk non-Hodgkin lymphoma.

Falzetti F, Di Ianni M, Ballanti S, Iodice G, Reale A, Minelli O, Serio G, Martelli MF, Dammacco F, Vacca A, Ria R.

Clin Exp Med. 2012 Sep;12(3):165-71. doi: 10.1007/s10238-011-0157-2. Epub 2011 Sep 18.

PMID:
21928053
27.

Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation.

Di Ianni M, Falzetti F, Carotti A, Terenzi A, Del Papa B, Perruccio K, Ruggeri L, Sportoletti P, Rosati E, Marconi P, Falini B, Reisner Y, Velardi A, Aversa F, Martelli MF.

Best Pract Res Clin Haematol. 2011 Sep;24(3):459-66. doi: 10.1016/j.beha.2011.05.005. Epub 2011 Jun 29.

PMID:
21925099
28.

The importance of bone marrow transplantation for patients who do not have a matched sibling donor.

Reisner Y, Martelli MF.

Best Pract Res Clin Haematol. 2011 Sep;24(3):323-4. doi: 10.1016/j.beha.2011.06.002. Epub 2011 Jul 29. No abstract available.

PMID:
21925084
29.

Haploidentical hematopoietic transplantation: current status and future perspectives.

Reisner Y, Hagin D, Martelli MF.

Blood. 2011 Dec 1;118(23):6006-17. doi: 10.1182/blood-2011-07-338822. Epub 2011 Sep 14. Review.

30.

Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation.

Di Ianni M, Falzetti F, Carotti A, Terenzi A, Castellino F, Bonifacio E, Del Papa B, Zei T, Ostini RI, Cecchini D, Aloisi T, Perruccio K, Ruggeri L, Balucani C, Pierini A, Sportoletti P, Aristei C, Falini B, Reisner Y, Velardi A, Aversa F, Martelli MF.

Blood. 2011 Apr 7;117(14):3921-8. doi: 10.1182/blood-2010-10-311894. Epub 2011 Feb 3.

31.

NPM1 deletion is associated with gross chromosomal rearrangements in leukemia.

La Starza R, Matteucci C, Gorello P, Brandimarte L, Pierini V, Crescenzi B, Nofrini V, Rosati R, Gottardi E, Saglio G, Santucci A, Berchicci L, Arcioni F, Falini B, Martelli MF, Sambani C, Aventin A, Mecucci C.

PLoS One. 2010 Sep 21;5(9):e12855. doi: 10.1371/journal.pone.0012855.

32.

NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL.

Sportoletti P, Baldoni S, Cavalli L, Del Papa B, Bonifacio E, Ciurnelli R, Bell AS, Di Tommaso A, Rosati E, Crescenzi B, Mecucci C, Screpanti I, Marconi P, Martelli MF, Di Ianni M, Falzetti F.

Br J Haematol. 2010 Nov;151(4):404-6. doi: 10.1111/j.1365-2141.2010.08368.x. Epub 2010 Aug 31. No abstract available.

PMID:
20813007
33.

CD34+ cells from AML with mutated NPM1 harbor cytoplasmic mutated nucleophosmin and generate leukemia in immunocompromised mice.

Martelli MP, Pettirossi V, Thiede C, Bonifacio E, Mezzasoma F, Cecchini D, Pacini R, Tabarrini A, Ciurnelli R, Gionfriddo I, Manes N, Rossi R, Giunchi L, Oelschlägel U, Brunetti L, Gemei M, Delia M, Specchia G, Liso A, Di Ianni M, Di Raimondo F, Falzetti F, Del Vecchio L, Martelli MF, Falini B.

Blood. 2010 Nov 11;116(19):3907-22. doi: 10.1182/blood-2009-08-238899. Epub 2010 Jul 15.

34.

Thymosin alpha1 to harness immunity to pathogens after haploidentical hematopoietic transplantation.

Perruccio K, Bonifazi P, Topini F, Tosti A, Bozza S, Aloisi T, Carotti A, Aversa F, Martelli MF, Romani L, Velardi A.

Ann N Y Acad Sci. 2010 Apr;1194:153-61. doi: 10.1111/j.1749-6632.2010.05486.x. Review.

PMID:
20536464
35.

Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults.

Gorello P, La Starza R, Varasano E, Chiaretti S, Elia L, Pierini V, Barba G, Brandimarte L, Crescenzi B, Vitale A, Messina M, Grammatico S, Mancini M, Matteucci C, Bardi A, Guarini A, Martelli MF, Foà R, Mecucci C.

Haematologica. 2010 Jan;95(1):79-86. doi: 10.3324/haematol.2009.010413.

36.

A NUP98-positive acute myeloid leukemia with a t(11;12)(p15;q13) without HOXC cluster gene involvement.

La Starza R, Brandimarte L, Pierini V, Nofrini V, Gorello P, Crescenzi B, Berchicci L, Matteucci C, Romoli S, Beacci D, Rosati R, Martelli MF, Mecucci C.

Cancer Genet Cytogenet. 2009 Sep;193(2):109-11. doi: 10.1016/j.cancergencyto.2009.04.015.

PMID:
19665072
37.

A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation.

Di Ianni M, Baldoni S, Rosati E, Ciurnelli R, Cavalli L, Martelli MF, Marconi P, Screpanti I, Falzetti F.

Br J Haematol. 2009 Sep;146(6):689-91. doi: 10.1111/j.1365-2141.2009.07816.x. Epub 2009 Jul 10. No abstract available.

PMID:
19604236
38.

Immunomagnetic isolation of CD4+CD25+FoxP3+ natural T regulatory lymphocytes for clinical applications.

Di Ianni M, Del Papa B, Cecchini D, Bonifacio E, Moretti L, Zei T, Ostini RI, Falzetti F, Fontana L, Tagliapietra G, Maldini C, Martelli MF, Tabilio A.

Clin Exp Immunol. 2009 May;156(2):246-53. doi: 10.1111/j.1365-2249.2009.03901.x. Epub 2009 Mar 9.

39.

Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm.

Facchetti F, Pileri SA, Agostinelli C, Martelli MP, Paulli M, Venditti A, Martelli MF, Falini B.

Haematologica. 2009 Feb;94(2):285-8. doi: 10.3324/haematol.13855. Epub 2008 Dec 9.

40.

Totipotent stem cells bearing del(20q) maintain multipotential differentiation in Shwachman Diamond syndrome.

Crescenzi B, La Starza R, Sambani C, Parcharidou A, Pierini V, Nofrini V, Brandimarte L, Matteucci C, Aversa F, Martelli MF, Mecucci C.

Br J Haematol. 2009 Jan;144(1):116-9. doi: 10.1111/j.1365-2141.2008.07448.x. Epub 2008 Nov 11.

PMID:
19016724
41.

Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation.

Velardi A, Ruggeri L, Mancusi A, Burchielli E, Perruccio K, Aversa F, Martelli MF; Immunobiology Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Semin Immunopathol. 2008 Dec;30(4):489-503. doi: 10.1007/s00281-008-0136-1. Epub 2008 Nov 11. Review.

PMID:
19002464
42.

A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: a risk factor analysis of outcomes for patients in remission at transplantation.

Ciceri F, Labopin M, Aversa F, Rowe JM, Bunjes D, Lewalle P, Nagler A, Di Bartolomeo P, Lacerda JF, Lupo Stanghellini MT, Polge E, Frassoni F, Martelli MF, Rocha V; Acute Leukemia Working Party (ALWP) of European Blood and Marrow Transplant (EBMT) Group.

Blood. 2008 Nov 1;112(9):3574-81. doi: 10.1182/blood-2008-02-140095. Epub 2008 Jul 7.

43.

A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).

Liso A, Castiglione F, Cappuccio A, Stracci F, Schlenk RF, Amadori S, Thiede C, Schnittger S, Valk PJ, Döhner K, Martelli MF, Schaich M, Krauter J, Ganser A, Martelli MP, Bolli N, Löwenberg B, Haferlach T, Ehninger G, Mandelli F, Döhner H, Michor F, Falini B.

Haematologica. 2008 Aug;93(8):1219-26. doi: 10.3324/haematol.13209. Epub 2008 Jul 4.

44.

t(3;11)(q12;p15)/NUP98-LOC348801 fusion transcript in acute myeloid leukemia.

Gorello P, Brandimarte L, La Starza R, Pierini V, Bury L, Rosati R, Martelli MF, Vandenberghe P, Wlodarska I, Mecucci C.

Haematologica. 2008 Sep;93(9):1398-401. doi: 10.3324/haematol.12945. Epub 2008 Jul 4.

45.

A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia.

Martelli MP, Manes N, Liso A, Pettirossi V, Verducci Galletti B, Bigerna B, Pucciarini A, De Marco MF, Pallotta MT, Bolli N, Sborgia M, di Raimondo F, Fabbiano F, Meloni G, Specchia G, Martelli MF, Falini B.

Leukemia. 2008 Dec;22(12):2285-8. doi: 10.1038/leu.2008.149. Epub 2008 Jun 19. No abstract available.

PMID:
18563173
46.

Comparative genomic hybridization identifies 17q11.2 approximately q12 duplication as an early event in cutaneous T-cell lymphomas.

Barba G, Matteucci C, Girolomoni G, Brandimarte L, Varasano E, Martelli MF, Mecucci C.

Cancer Genet Cytogenet. 2008 Jul;184(1):48-51. doi: 10.1016/j.cancergencyto.2008.03.007.

PMID:
18558289
47.

Skill reacquisition after acquired brain injury: a holistic habit retraining model of neurorehabilitation.

Martelli MF, Nicholson K, Zasler ND.

NeuroRehabilitation. 2008;23(2):115-26. Review.

PMID:
18525133
48.

Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.

Falini B, Martelli MP, Mecucci C, Liso A, Bolli N, Bigerna B, Pucciarini A, Pileri S, Meloni G, Martelli MF, Haferlach T, Schnittger S.

Haematologica. 2008 May;93(5):775-9. doi: 10.3324/haematol.12225. Epub 2008 Mar 26.

49.

Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin.

Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C, Volinia S, Liu CG, Schnittger S, Haferlach T, Liso A, Diverio D, Mancini M, Meloni G, Foa R, Martelli MF, Mecucci C, Croce CM, Falini B.

Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3945-50. doi: 10.1073/pnas.0800135105. Epub 2008 Feb 28.

50.

Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option.

Aversa F, Tabilio A, Velardi A, Terenzi A, Falzetti F, Carotti A, Aloisi T, Liga M, Di Ianni M, Zei T, Santucci A, Martelli MF.

Curr Stem Cell Res Ther. 2007 Jan;2(1):105-12.

PMID:
18220895

Supplemental Content

Loading ...
Support Center